{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:25:37Z","timestamp":1792481137218,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009730","name":"Stand up to Cancer","doi-asserted-by":"publisher","award":["SU2C#RT6186"],"award-info":[{"award-number":["SU2C#RT6186"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijrobp.2022.12.016","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T02:31:33Z","timestamp":1671503493000},"page":"560-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Endocrinopathy After Treatment for Medulloblastoma: Results From the SJMB03 Trial of Risk-Adapted Radiation Therapy"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-6255","authenticated-orcid":false,"given":"Thomas E.","family":"Merchant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Onar-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.12.016_bib0001","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/13854046.2020.1794045","article-title":"Neuropsychological functioning in survivors of childhood medulloblastoma\/CNS-PNET: The role of secondary medical complications","volume":"36","author":"Stadskleiv","year":"2022","journal-title":"Clin Neuropsychol"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0002","first-page":"82","article-title":"Core deficits and quality of survival after childhood medulloblastoma: A review","volume":"4","author":"Chevignard","year":"2017","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0003","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2007.07.2342","article-title":"Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma","volume":"70","author":"Merchant","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0004","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/08880018.2018.1471111","article-title":"Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma","volume":"35","author":"Bielamowicz","year":"2018","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuchi.2018.01.006","article-title":"Late effects of craniospinal irradiation for medulloblastomas in pediatric patients","volume":"67","author":"Bernier","year":"2021","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0006","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cen.12815","article-title":"Endocrine sequelae beyond 10 years in survivors of medulloblastoma","volume":"83","author":"Uday","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0007","doi-asserted-by":"crossref","unstructured":"Gajjar A, Robinson GW, Smith KS, et\u00a0al: Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03). J Clin Oncol 39:822-835, 2021","DOI":"10.1200\/JCO.20.01372"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0008","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","article-title":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial","volume":"7","author":"Gajjar","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0009","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2018.78.1492","article-title":"Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors","volume":"36","author":"Vatner","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0010","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2008.13.5293","article-title":"Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial","volume":"26","author":"Laughton","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0011","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000495943","article-title":"Hypogonadism in children with a previous history of cancer: Endocrine management and follow-up","volume":"91","author":"van Santen","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0012","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1210\/jc.2019-00539","article-title":"Clinical importance of free thyroxine concentration decline after radiotherapy for pediatric and adolescent brain tumors","volume":"104","author":"van Iersel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0013","first-page":"598","article-title":"Endocrinological late effects of oncologic treatment on survivors of medulloblastoma","volume":"90","author":"Hidalgo Santos","year":"2019","journal-title":"Rev Chil Pediatr"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0014","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of k-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Annals of Statistics"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00381-008-0742-1","article-title":"A scoring system to quantify late effects in children after treatment for medulloblastoma\/ependymoma and its correlation with quality of life and neurocognitive functioning","volume":"25","author":"Benesch","year":"2009","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0016","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/neuonc\/nov302","article-title":"Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma","volume":"18","author":"Eaton","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0017","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11060-016-2306-7","article-title":"Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: It is time to set aside old concerns","volume":"131","author":"Indini","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0018","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0360-3016(01)02788-2","article-title":"Radiation dose-volume effects on growth hormone secretion","volume":"52","author":"Merchant","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0019","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1210\/jc.2012-1978","article-title":"Pituitary function in patients with normal pressure hydrocephalus before and after neurosurgical correction","volume":"97","author":"Moin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0020","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1200\/JCO.2016.67.5025","article-title":"Prevalence and risk factors of early endocrine disorders in childhood brain tumor survivors: A nationwide, multicenter study","volume":"34","author":"Clement","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0021","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1200\/JCO.2011.37.9453","article-title":"Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors","volume":"29","author":"Merchant","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0022","doi-asserted-by":"crossref","first-page":"e742","DOI":"10.1097\/BPO.0000000000001339","article-title":"Clinical and radiographic characteristics of atypical slipped capital femoral epiphysis","volume":"39","author":"Chung","year":"2019","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0023","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.117.028753","article-title":"Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation","volume":"136","author":"Baumgartner","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0024","doi-asserted-by":"crossref","first-page":"88","DOI":"10.6065\/apem.2018.23.2.88","article-title":"Thyroid dysfunction in patients with childhood-onset medulloblastoma or primitive neuroectodermal tumor","volume":"23","author":"SY","year":"2018","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0025","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.ijrobp.2010.09.054","article-title":"Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma","volume":"82","author":"Cella","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0026","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11684-020-0752-2","article-title":"Long-term results of suppressing thyroid-stimulating hormone during radiotherapy to prevent primary hypothyroidism in medulloblastoma\/PNET and Hodgkin lymphoma: A prospective cohort study","volume":"15","author":"Massimino","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.ijrobp.2022.12.016_bib0027","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1215\/S1152851703000462","article-title":"Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy","volume":"6","author":"Xu","year":"2004","journal-title":"Neuro Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622036355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622036355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:11:08Z","timestamp":1789431068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622036355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0360301622036355"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.12.016","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrinopathy After Treatment for Medulloblastoma: Results From the SJMB03 Trial of Risk-Adapted Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}